Johnson & Johnson to pay $2.2B in U.S. health care fraud settlement

Allegations include paying kickbacks to physicians, pharmacies to recommend and prescribe antipsychotic drugs Risperdal and Invega, and heart failure drug Natrecor
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news